4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-013046
CHIEF COMMERCIAL OFFICER gave up 1,896 shares (to pay taxes)
- CHIEF COMMERCIAL OFFICER acquired 292 shares (grant or award)
- CHIEF COMMERCIAL OFFICER acquired 3,471 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-07-15 | Grant or award | +292 | $12.35 | $3,606 | 12,845 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-09-01 | Option exercise | +2,477 | 15,322 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-09-01 | Shares withheld for taxes | −1,353 | $17.76 | $24,029 | 13,969 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-09-02 | Option exercise | +994 | 14,963 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-09-02 | Shares withheld for taxes | −543 | $17.76 | $9,644 | 14,420 | D |
| Derivatives | |||||||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-09-01 | Option exercise · Restricted Share Unit | −2,477 | 7,431 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-09-01 | Grant or award · Restricted Share Unit | +6,445 | 6,445 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-09-01 | Grant or award · Share Option | +38,668 | 38,668 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2023-09-02 | Option exercise · Restricted Share Unit | −994 | 1,988 | D | ||
Loading xslF345X05/form4-09062023_110933.xml…